Cases & Deals

  • Home
  • Practices
  • Former senior executive of biopharmaceutical company defends DOJ and SEC investigations into alleged securities violations

Share

Former senior executive of biopharmaceutical company defends DOJ and SEC investigations into alleged securities violations

March 2024

Client(s) Former senior executive of biopharmaceutical company

Jones Day represents a former senior executive of a biopharmaceutical company in DOJ and SEC investigations into alleged securities violations.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.